About BITS Pilani

BITS Pilani is a Deemed-to-be University, offering on-campus programmes to more than 18,500 students across its campuses in Pilani, Goa, Hyderabad, Mumbai, and Dubai. It has been recognized as an Institute of Eminence by the Ministry of Education, Government of India, in 2020. In QS Asia University Rankings 2023, BITS has been ranked 188th, the only private institute from India in Asia Top 200, and at 18 in India. Further, BITS Pilani has been ranked among the top 300 in QS World University Graduate Employability Rankings 2022 and within the top 8 in India. Having pioneered several curricular and pedagogic attributes, BITS Pilani has a vision to be amongst the top research-led Institutes in the country. The qualities of innovation, enterprise, commitment to excellence, adherence to merit, and transparency have characterized the Institute during its inexorable march to eminence. The Institute has secured over ₹398 crores as external research funding in the last five years. State-of-the-art facilities have been developed to support cutting-edge research led by students and about 930 faculty members. This led to a Scopus h-index 156, with 221 patents filed and 41 patents granted. Currently, there are 14 BITSian Unicorns and 1 Decacorn. There are over 7500 BITSian founders and co-founders of enterprises.

The Department of Pharmacy at BITS Pilani, Pilani Campus, is one of the oldest pharmacy schools in the country; founded in 1950. Consistently ranked among the top five pharmacy schools by the National Institutional Ranking Framework ( in the Pharmacy category, the department has also achieved a remarkable QS World Ranking of 100 150 in Pharmacy and Pharmacology over the past two years. With a dedicated team of faculty members and over 60 research scholars, the department actively engages in diverse research domains. Its excellence is reflected in numerous patents, faculty-led startups, high-impact research publications, and industry funded projects. Several of its technologies have been successfully transferred to industry, with some products already available in the market, underscoring the department’s commitment to impactful research and innovation.

The field of neurological disorders encompasses a diverse range of conditions that affect millions of people worldwide, presenting significant challenges to both patients and healthcare providers. This conference aims to address these challenges by bringing together experts from various disciplines to discuss recent advancements in understanding, diagnosing, and treating neurological disorders. Key topics of discussion will include the latest research on the pathophysiology of neurological diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis, and amyotrophic lateral sclerosis (ALS) etc. We will explore innovative diagnostic techniques, including biomarkers and imaging technologies, which hold promise for earlier and more accurate detection of these conditions. Additionally, the conference will highlight cutting edge therapeutic approaches, from novel drug development to advanced neurostimulation techniques. Despite these advancements, numerous obstacles remain, such as the complexity of disease mechanisms, the need for personalized treatment strategies, and the ethical considerations surrounding emerging therapies.

Themes

Role of Genetics and Epigenetics in Neurological Disorders

Cellular and Molecular Pathways in Neurological Disorders

Innovations in Neuroimaging Techniques and Developing Biomarkers for Early Detection

Novel therapeutic approaches in the treatment of neurodegenerative disorder.

Advanced therapeutic approach for brain tumour, brain stroke, ischemia etc management

Natural/ herbal/ phytopharmaceutical based remedy in neurological disorder

Comorbidity associated with neurological disorder (Diabetes mellitus, obesity, anxiety etc)

Neurostimulation Techniques and Device-Based Therapies

Roadmap for the Next Decade in Neurological Disorder Management

Designing and Implementing Clinical Trials for Neurological Disorders

Challenges in Translating Research from Bench to Bedside

Challenges in Translating Research from Bench to Bedside